Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPAH
ISRCTN88782125Phase 3Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Dec 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of prednisolone and pentoxifylline in alcoholic hepatitis (AH) (4 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Mortality at 28 days. Started Dec 2009; status: completed.
02
Drugs
prednisolonepentoxifylline
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on ISRCTN88782125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN88782125.